Ketoprofen-loaded Eudragit RSPO microspheres: an influence of sodium carbonate on in vitro drug release and surface topology.
Eudragit RSPO microspheres containing ketoprofen as model drug, prepared by solvent evaporation technique using acetone-liquid paraffin (heavy) solvent system were examined. Depending upon polymer concentration in the internal phase, microspheres of particle mean diameter (122.8, 213.6 and 309.5 μm) were obtained. The influence of surface washing of microspheres with n-hexane, i.e. untreated microspheres (UM) on the drug content, drug release and surface topology of microspheres were compared to those of microspheres washed with sodium carbonate, i.e. treated microspheres (TM) in order to make the non-encapsulated surface drug soluble. The significant reduction in encapsulation efficiency (p < 0.001) and drug content (p < 0.001) after treatment, in combination with the small crystalline peaks observed during XRD testing and lack of melting endotherm observed in DSC testing, suggests that the washing process actually removes a significant amount of drug (p < 0.001) from the surface and encapsulated near to the surface of the microsphere polymer matrix. Scanning electron microscopy (SEM) examination revealed that the removal of surface drug did not affect the size of microspheres but the topology of treated smallest microspheres was modified. The ketoprofen release profiles were examined in phosphate buffer pH 7.4, using USPXXIII paddle type dissolution apparatus. In general both UM and TM result in biphasic release patterns, but the initial burst effect (first release phase) of TM was lower than that of UM. The second release phase did not change for the bigger size but increased for the smallest microspheres, probably owing to the modification of matrix porosity.
Pandit
Sachin S
SS
Laboratory of Pharmaceutics, Department of Pharmaceutical Sciences, R. T. M. Nagpur University, Nagpur, India. sachpandit@gmail.com
Hase
Dinesh P
DP
Bankar
Manish M
MM
Patil
Arun T
AT
Gaikwad
Naresh J
NJ
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage*; D002254:Carbonates / Q000737:chemistry*; D007660:Ketoprofen / Q000008:administration & dosage*; D008863:Microspheres; D011109:Polymethacrylic Acids / Q000737:chemistry*; D013499:Surface Properties
D000894:Anti-Inflammatory Agents, Non-Steroidal; D002254:Carbonates; C496966:Eudragit RSPO; D011109:Polymethacrylic Acids; C005686:sodium carbonate; D007660:Ketoprofen